Antonio Cano Selected Research

Atherosclerosis

6/2021	Variants translating reduced expression of the beta estrogen receptor gene were associated with increased carotid intima media thickness: A cross-sectional study in late postmenopausal women.
4/2015	Impact of estrogens on atherosclerosis and bone in the apolipoprotein E-deficient mouse model.
11/2010	Isoflavones and cardiovascular disease.
7/2008	Transdermal estradiol reduces F2alpha-isoprostane levels in postmenopausal women.
6/2008	Therapeutic dosages of oral or transdermal estradiol did not modify sCD40L levels in postmenopausal women.
1/2007	The risk for cardiovascular disease in women: from estrogens to selective estrogen receptor modulators.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Cano Research Topics

Disease

16	Neoplasms (Cancer) 05/2024 - 05/2003
14	Breast Neoplasms (Breast Cancer) 11/2023 - 04/2004
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 04/2004
6	Atherosclerosis 06/2021 - 01/2007
6	Osteoporosis 10/2020 - 08/2014
4	Endometriosis 01/2023 - 08/2003
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022 - 06/2020
4	Osteoporotic Fractures 01/2021 - 01/2011
3	Postmenopausal Osteoporosis 11/2023 - 01/2018
3	Insulin Resistance 04/2022 - 11/2010
3	Carcinogenesis 02/2022 - 01/2016
3	Chronic Disease (Chronic Diseases) 06/2021 - 08/2012
3	COVID-19 10/2020 - 04/2020
3	Multiple Sclerosis 01/2019 - 01/2016
3	Frailty 12/2018 - 01/2017
3	Coronary Disease (Coronary Heart Disease) 11/2012 - 12/2005
2	Infertility (Sterility) 08/2023 - 07/2014
2	Wounds and Injuries (Trauma) 03/2023 - 01/2021
2	Endometrial Hyperplasia 01/2023 - 03/2003
2	Hot Flashes 01/2023 - 01/2023
2	Atrophy 06/2021 - 10/2012
2	Urinary Incontinence 06/2021 - 03/2018
2	Obesity 10/2020 - 06/2020
2	Stress Urinary Incontinence 03/2018 - 02/2013
2	Hip Fractures (Intertrochanteric Fractures) 01/2017 - 01/2011
2	Bone Resorption 04/2015 - 04/2009
2	Stroke (Strokes) 11/2012 - 01/2007
1	Dyspareunia 05/2023
1	Infections 02/2023
1	Virus Diseases (Viral Diseases) 02/2023
1	Visceral Pain 01/2023
1	Pain (Aches) 01/2023
1	Sleep Wake Disorders 01/2023
1	Jet Lag Syndrome 01/2023
1	Chemical and Drug Induced Liver Injury 01/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2022
1	Ovarian Epithelial Carcinoma 02/2022
1	Type 2 Diabetes Mellitus (MODY) 02/2022
1	Inflammation (Inflammations) 10/2021
1	Migraine Disorders (Migraine) 07/2021
1	Urinary Tract Infections (Urinary Tract Infection) 06/2021
1	Urge Urinary Incontinence (Urge Incontinence) 01/2021
1	Osteoarthritis 01/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2020

Drug/Important Bio-Agent (IBA)

15	Hormones (Hormone)IBA 11/2023 - 09/2005
15	Estrogens (Estrogen)FDA Link 04/2022 - 04/2004
5	Selective Estrogen Receptor Modulators (SERM)IBA 11/2023 - 04/2004
5	LipidsIBA 04/2022 - 11/2010
4	Estrogen ReceptorsIBA 10/2018 - 03/2003
4	Estradiol (Delestrogen)FDA LinkGeneric 05/2010 - 09/2005
3	fezolinetantIBA 05/2024 - 01/2023
3	CalciumIBA 03/2023 - 02/2015
3	mahuang-tangIBA 12/2022 - 11/2018
3	AndrogensIBA 04/2022 - 10/2020
3	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 02/2022 - 06/2018
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 11/2015
3	Progestins (Progestagens)IBA 09/2021 - 01/2016
3	LigandsIBA 09/2021 - 01/2016
3	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2015
3	Tamoxifen FDA LinkGeneric 11/2018 - 03/2003
3	Raloxifene Hydrochloride (Evista)FDA Link 12/2005 - 02/2003
2	Denosumab FDA Link 11/2023 - 09/2014
2	Diphosphonates (Bisphosphonates)IBA 11/2023 - 01/2019
2	AntralIBA 08/2023 - 01/2020
2	Indoleacetic Acids (Auxin)IBA 03/2023 - 01/2021
2	MelatoninIBA 02/2023 - 01/2023
2	Alkaline PhosphataseIBA 01/2023 - 04/2009
2	EnzymesIBA 01/2023 - 04/2010
2	Messenger RNA (mRNA)IBA 02/2022 - 06/2018
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2019 - 12/2018
2	Contraceptive Agents (Contraceptives)IBA 11/2018 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 06/2018 - 01/2011
2	CD40 Ligand (CD40L)IBA 02/2016 - 06/2008
2	AntioxidantsIBA 07/2011 - 05/2003
1	Bone Density Conservation AgentsIBA 11/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	BilirubinIBA 01/2023
1	SmokeIBA 12/2022
1	CytokinesIBA 09/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021
1	erenumabIBA 07/2021
1	LubricantsIBA 06/2021
1	SteroidsIBA 05/2021
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2021
1	onabotulinum toxin AIBA 01/2021
1	Olive OilIBA 10/2020

Therapy/Procedure

14	Therapeutics 12/2023 - 02/2003
3	Drug Therapy (Chemotherapy) 12/2023 - 09/2014
3	Mediterranean Diet 12/2023 - 09/2020
2	Suburethral Slings (Tension-Free Vaginal Tape) 03/2018 - 02/2013
2	Ovariectomy (Oophorectomy) 04/2015 - 08/2014
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 04/2004 - 02/2003
1	Mastectomy (Mammectomy) 05/2023
1	Prophylactic Mastectomy 05/2023
1	Salpingo-oophorectomy 05/2023
1	Operative Surgical Procedures 05/2023
1	Duration of Therapy 12/2022
1	Injections 01/2021